Carmustine-impregnated wafers and their impact in the management of high-grade glioma

Author： La Rocca Renato V   Rezazadeh Arash  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.8, 2011-06, pp. : 1325-1332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carmustine implants costly in high-grade gliomas

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Targeting ErbB Receptors in High-Grade Glioma

By  

Current Pharmaceutical Design, Vol. 17, Iss. 23, 2011-08 ,pp. : 2468-2487

Bentham Science Publishers

Access to resources Recommend Favorite

Bevacizumab/carmustine: Fatal cerebrospinal fluid leak following carmustine-impregnated wafer placement: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis

By Rogers Gabriel   Garside Ruth   Mealing Stuart   Pitt Martin   Anderson Rob   Dyer Matthew   Stein Ken   Somerville Margaret  

PharmacoEconomics, Vol. 26, Iss. 1, 2008-01 ,pp. : 33-44

Adis International

Access to resources Recommend Favorite

Current and future directions for Phase II trials in high-grade glioma

By Alexander Brian M   Lee Eudocia Q   Reardon David A   Wen Patrick Y  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 4, 2013-04 ,pp. : 369-387

Informa Healthcare

Access to resources Recommend Favorite